Molecular Biotechnology

, 11:137 | Cite as

Rabies vaccine

Developments employing molecular biology methods
  • Claudio Carlos Paolazzi
  • Oscar Pérez
  • Javier De Filippo


Rabies vaccines produced by means of molecular biology are described. Recombinant vaccines employing either viruses as vectors (vaccinia, adenovirus, poxvirus, baculovirus, plant viruses) or a plasmid vector carrying the rabies virus glycoprotein gene are discussed. Synthetic peptide technology directed to rabies vaccine production is also presented.

Index Entries

Rabies vaccines DNA recombinant technology 


  1. 1.
    Pérez, O. and Paolazzi, C. C. (1997) Production methods for rabies vaccine.J. Ind. Microbiol. Biotechnol. 18, 340–347.CrossRefGoogle Scholar
  2. 2.
    Cox, J. H., Dietzchold, B., and Schneider, L. G. (1977) Rabies viruses glycoprotein II biological and serological characterization.Infect. Immunit. 16, 754–759.Google Scholar
  3. 3.
    Anilionis, A., Wunner W. H., and Curtis, P. J. (1981) Structure of the glycoprotein gene in rabies virus.Nature 294, 275–278.CrossRefGoogle Scholar
  4. 4.
    Wiktor, T. J., Gyorgy, E., Schulmberger, H. D., Sokol, F., and Koprowski, H. (1973) Antigenic properties of rabies virus components.J. Immunol. 110, 269–276.Google Scholar
  5. 5.
    Sikes, R. K., Cleary, W. F., Koprowski, H., Wiktor, T. J., and Kaplan, M. M. (1977) Effective protection of monkeys against death from street virus by post-exposure administration of tissue culture rabies vaccine.Bull. W. H. O. 45, 1–11.Google Scholar
  6. 6.
    Flamand, A., Wiktor, T. J., and Koprowski, H. (1980) Use of hybridoma monoclonal antibodies in the detection of antigenic differences between rabies and rabies related virus proteins II glycoprotein.J. Gen. Virol. 48a, 105–109.CrossRefGoogle Scholar
  7. 7.
    Tsiang, H. and Lagrange, P. H. (1980) In vitro detection of cell mediated immunity in street rabies infection in mice.J. Gen. Virol. 47, 183–191.CrossRefGoogle Scholar
  8. 8.
    Flamand, A., Wiktor, T. J., and Koprowski, H. (1980) Use of hybridoma monoclonal antibodies in the detection of antigenic differences between rabies and rabies related virus proteins and the nucleocapside protein.J. Gen. Virol. 48, 97–104.CrossRefGoogle Scholar
  9. 9.
    Dietzschold, B., Wunner, W. H., Wiktor, T. J., Lopes, A. D., Lafon, M., Smith, C. L., and Koprowski, H. (1983) Characterization of antigenic determinant of the glycoprotein that correlates with pathogenicity of rabies virus.Proc. Natl. Acad. Sci. USA 80, 70–74.CrossRefGoogle Scholar
  10. 10.
    Dietzschold, B., Wang, H., Rupprecht, C. E., Celis, M, Tollis, H., Herber Katz, E., and Koprowski, H. (1987) Induction of protective immunity against rabies by immunization with rabies virus ribonucle-oprotein.Proc. Natl. Acad. Sci. USA. 84, 9165–9169.CrossRefGoogle Scholar
  11. 11.
    Malek, L. T., Soostmeyer, G., Garvin, T., and James, E. (1984) The rabies glucoprotein gene is expressed inEscherichia coli as denatured polypeptide. Modern approaches in vaccines: molecular and chemical basis of virus virulence and immunity, Channock, R. M. and Lerner, R. A. (Eds.), Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY1, 203–208.Google Scholar
  12. 12.
    Old, R. W. and Primrose, S. B. (1990) Principles of genetic manipulation. Blackwell Scientific Publications 4th on line ed., Oxford University Press, Oxford, UK.Google Scholar
  13. 13.
    Maniatis, T., Fritsch, E. F., and Sambrook, J. (1982)Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.Google Scholar
  14. 14.
    Sanger, F., Niklen, S., and Coulson, A. R. (1977) DNA sequencing with chain terminating inhibitors.Proc. Natl. Acad. Sci. USA,74, 5463–5467.CrossRefGoogle Scholar
  15. 15.
    Yelverton, E., Norton, S., Obijeski, J. F., and Goedel, D. (1983) Rabies virus glycoprotein analogs biosynthesis inE. coli.Science 29, 614–620.CrossRefGoogle Scholar
  16. 16.
    Mackett, M., Smith, G. L., and Moss, B. (1982) Vaccinia virus: A selectable eukaryotic cloning and expression vector.Proc. Natl. Acad. Sci. USA 79, 7415–7419.CrossRefGoogle Scholar
  17. 17.
    Prevec, L., Campbell, J. B., Christie, B. S., Belbeck, L., and Graham, F. L. (1990) A recombinant adenovirus vaccine against rabies.J. Infect. Diseases 161, 27–30.Google Scholar
  18. 18.
    Schneider, M., Graham, F. L., and Prevec, L. (1989) Expression of the glycoprotein of vesicular stomatitis virus by infectious adenovirus vectors.J. Gen. Virol. 70, 417–427.CrossRefGoogle Scholar
  19. 19.
    Graham, F. L. (1990) Adenovirus as expression vectors and recombinant vaccines.Trends Biotechnol 8, 85–87.CrossRefGoogle Scholar
  20. 20.
    Panicali, D. and Paoletti, E. (1982) Construction of poxvirus as cloning vectors insertion of the thymidine kinase gene from herpes simplex virus into the DNA of infectious vaccinia virus.Proc. Natl. Acad. Sci. USA 79, 4927–4931.CrossRefGoogle Scholar
  21. 21.
    Kozak, M. (1981) Possible role of Hanking nucleotides in the recognition of the AUG initiation codon by eukaryotic ribosomes.Nucleic Acid Res. 9, 5232–5233.Google Scholar
  22. 22.
    Kozack, M. (1984) Point mutations close to the AUG initiation codon affect the efficiency of translation of the rat preproinsulin in vivo.Nature 308, 241–246.CrossRefGoogle Scholar
  23. 23.
    Kieny, M. P., Lathe, R., Dritten, R., Spehner, D., Skory, S., Schmitt, D., Wiktor, T. J., Koprowski, H., and Lecocq, J. P. (1984) Expression of rabies virus glycoprotein from a recombinant vaccinia virus.Nature 312, 163–166.CrossRefGoogle Scholar
  24. 24.
    Wiktor, T. J., Mac Farlan, R. J., Reagan, K. J., Dietzschold, B., Curtis, P. J., Wunner, W. H., Kieny, M. P., Lathe, R. M, Lecocq, J. P., Mackett, M., Moss, B., and Koprowski, H. (1984) Protection from rabies by vaccinia virus recombinant containing the rabies virus glycoprotein gene.Proc. Natl. Acad. Sci. USA 81, 7194–7198.CrossRefGoogle Scholar
  25. 25.
    Piccini, A., Perkus, M. E., and Paoletti, E. (1987) Vaccinia virus as an expression vector.Methods Enzymol. 153, 545–563.CrossRefGoogle Scholar
  26. 26.
    Blancou, J., Kieny, M. P., Lathe, R., Lecocq, J. P., Pastoret, P. P., Soulebot J. P., and Desmettre, P. (1986) Oral vaccination of the fox against rabies using a live recombinant vaccinia virus.Nature 322, 373.CrossRefGoogle Scholar
  27. 27.
    Rupprecht, Ch. E., Wiktor, T. J., Johnston, D. H., Hamir, A. N., Dietzschold, B., Wunner, W. H., Glickman, L. T., and Koprowski, H. (1986) Oral immunization and protection of raccoonsProcyon lotor with vaccinia rabies glycoprotein recombinant virus vaccine.Proc. Natl. Acad. Sci. USA 83, 7947–7950.CrossRefGoogle Scholar
  28. 28.
    Brochier, B., Kieny, M. P., Costy, F., Coppens, P., Bauduin, B., Lecocq, J. P., Languet, B., Chappuis, G., Desmettre, P., Afiademanyo, K., Libois, R., and Pastoret, P. P. (1991) Large scale eradication of rabies using recombinant vaccinia rabies vaccine.Nature 354, 520–522.CrossRefGoogle Scholar
  29. 29.
    Summer, J. W., Fekadu, M., Shaddock, J. H., Esposito J. J., and Bellini, W. J. (1991) Construction of vaccinia virus recombinants that express the rabies nucle-oprotein and protective immunization of mice.J. Virol. 183, 703–710.CrossRefGoogle Scholar
  30. 30.
    Fekadu, M., Summer, J. W., Shaddock, J. H., Sanderlin, D. W., and Baer, G. M. (1992) Sickness and recovery of dogs challenged with street rabies virus after vaccination with vaccinia virus recombinant expressing rabies virus N protein.J. Virol. 66, 2601–2604.Google Scholar
  31. 31.
    Prevec, L., Schneider, M., Rosenthal, K. L., Belbeck, L. W., Derbyshire, J. B., and Graham, F. L. (1989) Use of adenovirus based vectors for antigen expression in animals.J. Gen. Virol. 70, 429–434.CrossRefGoogle Scholar
  32. 32.
    Xiang, Z. Q., Yiping, Y., Wilson, J. M, and Erlt, H. C. J. (1996) A replication-defective human adenovirus recombinant serves as a highly efficacious vaccine carrier.Virology 219, 220–227.CrossRefGoogle Scholar
  33. 33.
    Wang, Y., Xiang, Z. Q., Pasquini, S., and Erlt, H. C. J. (1997) The use an El-deleted, replication-defective adenovirus recombinant expressing the rabies virus glycoprotein for early vaccination of mice against rabies virus.J. Virol. 71, 3677–3683.Google Scholar
  34. 34.
    Fries, L. F., Tartaglia, J., Taylor, J., Kauffman, E. K., Meignier, B., Paoletti, E., and Plotkin, S. (1996) Human safety and immunogenicity of canaripoxrabies glycoprotein recombinant vaccine an alternative poxvirus vector system.Vaccine 14, 428–434.CrossRefGoogle Scholar
  35. 35.
    Prehaud, C, Takehara, K., Flamand, A., and Bishop, D. H. L. (1989) Immunogenic and protective properties of virus glycoprotein expressed by baculovirus vectors.Virology 173, 390–399.CrossRefGoogle Scholar
  36. 36.
    Prehaud, C, Harris, R. D., Fulop, V., Koh, Ch. L., Wong, J., Flamand, A., and Bishop, D. H. L. (1990) Expression, characterization and purification of phos-phorylated rabies nucleoprotein synthesized in insect cells by baculovirus.Virology 178, 486–497.CrossRefGoogle Scholar
  37. 37.
    Matsura, Y., Possee, R., Overton, H. A., and Bishop, D. H. L. (1987) Baculovirus expression vectors, the requirements of expression proteins including glycoproteins.J. Gen. Virol. 68, 1233–1250.CrossRefGoogle Scholar
  38. 38.
    Fu, Z. F., Dietzschold, B., Schumacher, C. L., Wunner, W. H., Ertl, H. C. J., and Koprowski, H. (1991) Rabies virus nucleoprotein expressed in and purified from insect cells is efficacious as vaccine.Proc. Natl. Acad. Sci. USA 88, 2001–2005,CrossRefGoogle Scholar
  39. 39.
    Yusibov, V., Modelska, A, Steplewski, K., Agadjanyan, M., Weiner, D., Hooper, D. C, and Koprowski, H. (1997) Antigens produced in plants by infections with chimeric plant-viruses immunize against rabies virus and HIV-1.Immunology 94, 5784–5788.Google Scholar
  40. 40.
    Xiang, Z. Q., Spitalnik, S., Tran, M., Wunner, W. H., Cheng, J., and Erlt, H. C. J. (1994) Vaccination with a plasmid vector carrying the rabies virus glycoprotein gene induces protective immunity against rabies virus.Virology 199, 132–140.CrossRefGoogle Scholar
  41. 41.
    Xiang, Z. Q. and Erlt, H. C. J. (1995) Manipulation of the immune response to a plasmid encoded viral antigen by coinoculation with plasmids expressing cytokines.Immunity 2, 129–135.CrossRefGoogle Scholar
  42. 42.
    Crick, J. and Brown, F. (1969) Viral subunits for rabies vaccination.Nature 222, 92.CrossRefGoogle Scholar
  43. 43.
    Wunner, V. H., Dietzschold, B., Curtis, P. J., and Wiktor, T. J. (1983) Rabies subunit vaccines.J. Gen. Virol. 64, 1649–1656.CrossRefGoogle Scholar
  44. 44.
    Morein, B. and Simons, K. (1985) Subunit vaccines against enveloped viruses: virosomes, micelles and other protein immune complex.Vaccine 3, 83–93.CrossRefGoogle Scholar
  45. 45.
    Koprowski, H. (1988) Glimpses into the future of rabies research.Rev. Infect. Dis. 10 (suppl. 4), 810–813.Google Scholar
  46. 46.
    Castingolles, N., Morgeaux, S., Gontier-Jallet, C., Sarnain, D., Betbeder, D., and Perrin, P. (1996) A new family of carriers (biovectors) enhances the immunogenicity of rabies antigens.Vaccine 14, 1353–1360.CrossRefGoogle Scholar
  47. 47.
    Ertl, H., Varga, Y., Xiang, Z. Q., Kaiser, K., La Donna, E., and Otvos, L. (1996) Poly (DL. lactide-co-gycolide) microspheres as carriers for peptide vaccine.Vaccine 14, 879–885.CrossRefGoogle Scholar

Copyright information

© Humana Press Inc. 1999

Authors and Affiliations

  • Claudio Carlos Paolazzi
    • 1
  • Oscar Pérez
  • Javier De Filippo
  1. 1.Servicio Vacuna AntirrábicaInstituto Nacional de Produccion de Biologicos, A.N.L.I.S.Argentina

Personalised recommendations